Phase 2 Study of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Longer Follow up, Poster Nr. 367, presented at American Society of Clinical Oncology (ASCO) - Rischin, D; Midgen, M R; Lim, A M (2020)
et al.